Cite
HARVARD Citation
Park, J. et al. (2014). SAT0317 Baseline MRA Predicts the Treatment Response to Vasodilator Udenafil in Patients with Secondary Raynaud's Phenomenon. Annals of the rheumatic diseases. p. 707. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Park, J. et al. (2014). SAT0317 Baseline MRA Predicts the Treatment Response to Vasodilator Udenafil in Patients with Secondary Raynaud's Phenomenon. Annals of the rheumatic diseases. p. 707. [Online].